| | | | | | | | | | | | | | | | | | | | | |
Ownership Document |
Schema Version: X0508 |
Document Type: 4 |
Period of Report: 2/15/24 |
Issuer: |
| Issuer CIK: 1411690 |
| Issuer Name: Bionano Genomics, Inc. |
| Issuer Trading Symbol: BNGO |
Reporting Owner: |
| Reporting Owner ID: |
| | Owner CIK: 1821605 |
| | Owner Name: Chaubey Alka |
| Reporting Owner Address: |
| | Owner Street 1: C/O BIONANO GENOMICS, INC. |
| | Owner Street 2: 9540 TOWNE CENTRE DRIVE, SUITE 100 |
| | Owner City: SAN DIEGO |
| | Owner State: CA |
| | Owner ZIP Code: 92121 |
| | Owner State Description: |
| Reporting Owner Relationship: |
| | Is Director? No |
| | Is Officer? Yes |
| | Is Ten Percent Owner? No |
| | Is Other? No |
| | Officer Title: CHIEF MEDICAL OFFICER |
| | Other Text: |
Aff 10b5 One: 0 |
Non-Derivative Table: |
| Non-Derivative Transaction: |
| | Security Title: |
| | | Value: Common Stock |
| | Transaction Date: |
| | | Value: 2/15/24 |
| | Transaction Coding: |
| | | Transaction Form Type: 4 |
| | | Transaction Code: F |
| | | Equity Swap Involved? No |
| | | Footnote ID: F1 |
| | Transaction Amounts: |
| | | Transaction Shares: |
| Value: 1,081 |
| Footnote ID: F1 |
| | | Transaction Price Per Share: |
| Value: 1.27 |
| | | Transaction Acquired-Disposed Code: |
| Value: D |
| | Post-Transaction Amounts: |
| | | Shares Owned Following Transaction: |
| Value: 31,487 |
| Footnote ID: F2 |
| Footnote ID: F3 |
| | Ownership Nature: |
| | | Direct or Indirect Ownership: |
| Value: D |
| | | Nature of Ownership: |
| Value: |
Derivative Table: |
Footnotes: |
| Footnote - F1: The reporting person is reporting the withholding by the Issuer of an aggregate of 1,081 shares of common stock in connection with shares that vested on February 15, 2024 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. |
| Footnote - F2: On August 4, 2023, the common stock of Bionano Genomics, Inc. split 1-for-10, resulting in the reporting person's ownership of 112,315 less shares of common stock. |
| Footnote - F3: Includes 89 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan on June 12, 2023. |
Owner Signature: |
| Signature Name: /s/ Jonathan V. Dixon, Attorney-in-Fact |
| Signature Date: 3/5/24 |